COBIK

🔊 Excited to be part of the 𝟮𝗻𝗱 𝗦𝗹𝗼𝘃𝗲𝗻𝗶𝗮𝗻 𝗣𝗵𝗮𝗴𝗲 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 at the University of Ljubljana, Biotechnical Faculty!   🔉 The event kicked off with an opening session by Rob Lavigne, who delivered an insightful lecture on phage biology and its diverse applications. 🔉 We’re especially looking forward to the 3rd session at 4 PM, where our very own Martina Durcik will present the recently published clinical use of 𝗦. 𝗲𝗽𝗶𝗱𝗲𝗿𝗺𝗶𝗱𝗶𝘀 𝗽𝗵𝗮𝗴𝗲𝘀, along with the research and development journey behind it.   #Bacteriophages #PhageTherapy #Sepidermidis #Meeting #COBIK

🌟 COBIK Phages Are Reaching Patients! 🌟 At COBIK, we’ve dedicated over a decade to advancing phage science, isolating numerous bacteriophages, and conducting rigorous preclinical testing on animal models. Our unwavering focus has been on ensuring the therapeutic suitability and uncompromising quality of phage products. We are thrilled to share that 𝗖𝗢𝗣-𝟴𝟬𝗕, a bacteriophage isolated, characterized, and manufactured by COBIK, was successfully used to treat a patient with a 𝗽𝗲𝗿𝗶𝗽𝗿𝗼𝘀𝘁𝗵𝗲𝘁𝗶𝗰 𝗷𝗼𝗶𝗻𝘁 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 in the right knee. 📄 The case is detailed in a recent publication: https://lnkd.in/eg8e53RF In short, there was no adverse effects and six months post-treatment, the patient is 𝗽𝗮𝗶𝗻-𝗳𝗿𝗲𝗲 with a 𝗳𝘂𝗹𝗹𝘆 𝗵𝗲𝗮𝗹𝗲𝗱 𝘀𝘂𝗿𝗴𝗶𝗰𝗮𝗹 𝘄𝗼𝘂𝗻𝗱. This successful treatment reflects our unwavering commitment to improving patients' lives and the incredible partnerships that have made it possible. We extend our heartfelt gratitude to: 🤝 𝗝𝗼𝘀𝗵 𝗝𝗼𝗻𝗲𝘀 from UK Phage Therapy 🤝 Our Slovenian collaborators: BIA Separations Inc. (Sartorius), Nika Janez, University of Ljubljana, Biotechnical Faculty and Ortopedska bolnišnica Valdoltra Ankaran Slovenia. Together, we are paving the way for innovative solutions to combat antimicrobial resistance. 🔬 Stay tuned as we continue to push the boundaries of bacteriophage research and therapy! #Bacteriophage #PhageTherapy #Innovation #AntimicrobialResistance #COBIK #Collaboration

🔊 Less than a week to go! 🔊 📅 We’re counting down to the 𝟮𝗻𝗱 𝗦𝗹𝗼𝘃𝗲𝗻𝗶𝗮𝗻 𝗣𝗵𝗮𝗴𝗲 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 on 𝗝𝗮𝗻𝘂𝗮𝗿𝘆 𝟮𝟯, 𝟮𝟬𝟮𝟱! COBIK is pleased to be part of this exciting event, where our colleague Martina Durcik will present our latest advancements in the dynamic field of 𝗽𝗵𝗮𝗴𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁. This is a fantastic opportunity to connect, network, and collaborate with fellow phage enthusiasts from academia and industry. 🔊 A special shoutout to Anna Dragos, University of Ljubljana, Biotechnical Faculty, JAFRAL Biosolutions and University of Ljubljana, Faculty of Chemistry and Chemical Technology for their contributions to making this event possible. Looking forward to seeing you there! https://lnkd.in/dVwvMJNu #PhageResearch #PhageInnovation #Networking #ScientificCommunity

🔊 Developing an efficient and scalable manufacturing process for high-quality plasmid DNA is a complex and challenging task. The COBIK team is proud to have contributed to this groundbreaking study by developing a superior manufacturing process for IL-12 plasmid DNA. 🔊 Congratulations to the Institute of Oncology Ljubljana on achieving this significant milestone in advancing cancer treatment, and heartfelt thanks to all the partners who played a crucial role in this success. JAFRAL Biosolutions, Iskra PIO University of Ljubljana, Faculty of Electrical Engineering, Institute of Oncology Ljubljana #COBIK #plasmid #Manufacturing #BioprocessDevelopment #GeneTherapy #CancerResearch #ClinicalTrials #electroporation #interleukin12

🔊 Congratulations to our colleague Urban Bezeljak for having the most cited article in Radiology and Oncology titled "Cancer gene therapy goes viral: viral vector platforms come of age"! Check out his article through the link below! ⬇ https://lnkd.in/ebrzZtxs #COBIK #Oncology #article #genetherapy

🔊 We are thrilled to announce our contribution to the Slovenian Veterinary Research journal with our editorial, ‘Rediscovering Phage Therapy: A Promising Approach for Combating Antimicrobial Resistance.’ ⚗ 🔊 In this piece, we highlight the critical issue of antimicrobial resistance and explore how phage therapy could be a powerful solution. We also examine its applications in veterinary medicine and discuss the current regulatory landscape for phage product development.🐶🐱🐴 🔊 For a deeper dive into the potential of phage therapy in small animal veterinary medicine, check out also the article, ‘Skin Dysbiosis in Atopic Dogs: Is Phage Therapy an Alternative to Antibiotics?’ here: https://lnkd.in/ewxBWMbB. #COBIK #phagetherapy #veterinarymedicine #antimicrobialresistance #research

☀ Greetings from Piran! ☀ COBIK team took a refreshing day off to soak up the sun on the beautiful Slovenian coast. We explored the charming town of Piran and enjoyed a delightful boat trip complete with a fish picnic! Now, we're back in the lab, energized and ready to continue developing groundbreaking technologies. 🌊🌞 #COBIK #Teambuilding

🔊 See you next week in Malta! 😎 #COBIK #Targeting Phage Therapy #bacteriophages #conference

🔊 TBT last week in Portorož! ⛱ 🌟 Last Friday, we had the privilege of hearing our talented colleague, Vida Štilec, present her groundbreaking research on #bacteriophages. Her insights were truly fascinating and inspiring! 🌟 A heartfelt thank you to MSS Events for organizing such a fantastic conference. We can't wait for the next one! #COBIK #conference #MSS2024 #Biotechnology #mRNA #pDNA #bacteriophages #AAV #genetherapy

🔊 Greetings from MSS Events in Portorož! 🌟 Yesterday, our Tjaša Marušič had the honor of presenting her master’s thesis on optimizing #mRNA production using #DoE. 🌟 We are thrilled to be attending talks with the world's leading researchers in #MonolithTechnology. 🌟 At COBIK, monolith columns are integral to our daily routine for purifying and analyzing #pDNA, #mRNA, #VLPs, #Bacteriophages, and other biological molecules. We’re excited to implement some of the new discoveries into our protocols! 👩🔬👨🔬 🌟 Interested in our work or potential collaborations? Please visit our booth! #COBIK #Conference #MSS2024 #Monolith #mRNA #pDNA #Bacteriophages #Biotechnology #SARTORIUS